Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Velosbio Emerges With $58M In Funding To Steer Cancer Drugs To Clinic
Venture Capital

Xconomy: Velosbio Emerges With $58M In Funding To Steer Cancer Drugs To Clinic

by xconomy.com posted 8months ago 23 views
VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX) and Sofinnova Ventures. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The company is developing antibody drug conjugates, a class […]

In this article